Archive - Asymmetric Learning - Pharmaceutical Innovation

The Optionality Orchard

How Early-Phase Bets Can Turn Pharma’s Patent Cliff into a Gold Rush

Oct 21 •

Mike Rea, IDEA Pharma

Mastering the Mind: The Interplay of Conclusions, Biases, and Heuristics in Reasoning and Learning

This article, like so many, started with me wondering what a particular word means, at its core.

Oct 20 •

Mike Rea, IDEA Pharma

Embracing the Unknown: Feynman’s “Satisfactory Philosophy of Ignorance”

I was chatting with one of my favourite clients this morning, on the cool direction she’s taking her company, with a search for what’s not known, vs…

Oct 15 •

Mike Rea, IDEA Pharma

When Oncology KOLs Disagree, Whose Judgment Is Right?

Transforming Conflict into Strategic Foresight

Oct 14 •

Mike Rea, IDEA Pharma

Gradually, then suddenly

Beating the status quo bias: shifting pharma from the wrong decision process to a better one...

Oct 9 •

Mike Rea, IDEA Pharma

Information, Intelligence, Creativity, and Asymmetric Learning: Why Curiosity Fuels Pharma’s Edge

Have you ever found yourself buried in a Phase II dataset, staring at numbers that just won’t tell you anything?

Oct 4 •

Mike Rea, IDEA Pharma

From white goods to white space

How Competitive Intelligence is shaping the pharmaceutical industry landscape

Oct 3 •

Mike Rea, IDEA Pharma

Why Linear Learning is Killing Pharma Innovation

Time for Big, Uneven Leaps

Oct 1 •

Mike Rea, IDEA Pharma

September 2025

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts